person · Reporting owner
Douglas Robert Andrew
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Director | January 21, 2026 | January 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date January 21, 2026 · Filed January 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $94.15 · Expires 2036-01-21 | Direct | 15,000 |
Reported balance
After 2026-01-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-21 · Grant · Acquired 15,000 · Balance 15,000 F1: These options were granted on January 21, 2026, and will vest on January 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on January 21, 2026, and will vest on January 1, 2027.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
RESMED INC
Report date January 02, 2024 · Filed January 03, 2024
Section 16 reporting ended · disclosed 2024-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 11,080 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,080 F1: Mr. Douglas is no longer subject to reporting under his new role. |
| ResMed Common StockSEC Table I · non-derivative | IndirectDouglas Family Trust | 253,295 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 253,295 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Douglas is no longer subject to reporting under his new role.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2026 Filed Jan 23, 2026 22:01 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $94.15 | $0.00 |
DisclosureSEC source: 0001193125-26-021234 · ownership.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2036-01-21 F1 · derivative.exercise_date: These options were granted on January 21, 2026, and will vest on January 1, 2027. Read SEC document |
| January 23, 2025 Filed Mar 28, 2025 23:13 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $92.42 | $0.00 |
DisclosureSEC source: 0000950170-25-047051 · ownership.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2035-01-23 F1 · derivative.exercise_date: These options were granted on January 23, 2025, and will vest on January 1, 2026. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 22:06 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $53.75 | $0.00 |
DisclosureSEC source: 0000950170-24-008951 · ownership.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2034-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2024, and will vest on January 1, 2025. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 00:06 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 1,375.219 | $148.94 | $204,825.12 |
DisclosureSEC source: 0001127602-23-028064 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,849 F1 · kind: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:23 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 759.74 | $143.60 | $109,098.66 |
DisclosureSEC source: 0001127602-23-027465 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,224 F2 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021. F3 · balance_after: Includes 54.45 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 01:23 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 944.542 | $143.60 | $135,636.23 |
DisclosureSEC source: 0001127602-23-027465 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,985 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 17:51 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $181.01 | $271,515.00 |
DisclosureSEC source: 0001127602-23-022703 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · Douglas Family Trust Disclosed balance after: 250,526 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 21:02 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $222.22 | $333,330.00 |
DisclosureSEC source: 0001127602-23-020952 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · Douglas Family Trust Disclosed balance after: 252,026 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 16:02 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $216.27 | $324,405.00 |
DisclosureSEC source: 0001127602-23-018944 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · Douglas Family Trust Disclosed balance after: 253,526 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. Read SEC document |
| May 15, 2023 Filed May 16, 2023 22:07 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $232.85 | $349,275.00 |
DisclosureSEC source: 0001127602-23-015793 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · Douglas Family Trust Disclosed balance after: 255,026 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 01:10 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $224.65 | $336,975.00 |
DisclosureSEC source: 0001127602-23-013175 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Plan reported Ownership: Indirect · Douglas Family Trust Disclosed balance after: 256,526 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:14 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $206.14 | $309,210.00 |
DisclosureSEC source: 0001127602-23-010444 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 258,026 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:14 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 1,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-010444 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 259,526 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan adopted February 9, 2023. F2 · kind: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 00:12 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $213.50 | $320,250.00 |
DisclosureSEC source: 0001127602-23-005682 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 261,445 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · balance_after: Includes a transfer of shares between direct and indirect holdings on 2/8/2023. Read SEC document |
| January 26, 2023 Filed Feb 27, 2023 21:56 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $75.18 | $0.00 |
DisclosureSEC source: 0001209191-23-013230 · doc4.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2033-01-26 F1 · derivative.exercise_date: These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 21:30 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 1,500 | $220.43 | $330,645.00 |
DisclosureSEC source: 0001127602-23-001652 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 226,208 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 23, 2022 Filed Nov 23, 2022 23:24 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 19,425 | $224.40 | $4,358,970.00 |
DisclosureSEC source: 0001127602-22-026361 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,556 F2 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019. Read SEC document |
| November 23, 2022 Filed Nov 23, 2022 23:24 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 32,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026361 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,981 F1 · kind: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met. Read SEC document |
| November 16, 2022 Filed Nov 19, 2022 01:08 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 31,649 | $224.58 Strike: $224.58 | $7,107,732.42 |
DisclosureSEC source: 0001127602-22-026099 · form4.xml · derivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,649 Underlying: ResMed Common Stock · 31,649 shares Expires 2029-11-16 F1 · derivative.exercise_date: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 16,888 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-025832 · form4.xml · derivative · entry 6 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 16,888 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 1,144 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-025832 · form4.xml · derivative · entry 5 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,888 Underlying: ResMed Common Stock · 1,144 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 11,280 | $222.07 | $2,504,939.45 |
DisclosureSEC source: 0001127602-22-025832 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,186 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $221.77 $223.56. The price reported above reflects the weighted average sale price. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 16,888 | $58.24 | $983,557.12 |
DisclosureSEC source: 0001127602-22-025832 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 1,144 | $58.24 | $66,626.56 |
DisclosureSEC source: 0001127602-22-025832 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 23:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 760 | $225.18 | $171,136.80 |
DisclosureSEC source: 0001127602-22-025659 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,434 F2 · kind: Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021. F3 · balance_after: Includes 52.908 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 23:54 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 945 | $225.18 | $212,795.10 |
DisclosureSEC source: 0001127602-22-025659 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,194 F1 · kind: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2020. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 23:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 16,888 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-023989 · form4.xml · derivative · entry 6 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,032 Underlying: ResMed Common Stock · 16,888 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 23:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 1,145 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-023989 · form4.xml · derivative · entry 5 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,920 Underlying: ResMed Common Stock · 1,145 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 23:25 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 11,355 | $215.09 | $2,442,298.12 |
DisclosureSEC source: 0001127602-22-023989 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,086 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $213.62 to $217.36. The price reported above reflects the weighted average sale price. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 23:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 16,888 | $58.24 | $983,557.12 |
DisclosureSEC source: 0001127602-22-023989 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,441 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| October 14, 2022 Filed Oct 17, 2022 23:25 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 1,145 | $58.24 | $66,684.80 |
DisclosureSEC source: 0001127602-22-023989 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 16,888 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · derivative · entry 7 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,065 Underlying: ResMed Common Stock · 16,888 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 1,145 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · derivative · entry 6 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,953 Underlying: ResMed Common Stock · 1,145 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 1,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · nonDerivative · entry 5 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 227,708 F3 · kind: Gift of shares to Fidelity Charitable, a donor advised fund. Mr. Douglas has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 6,000 | $232.38 | $1,394,280.00 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · nonDerivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Douglas Family Trust Disclosed balance after: 228,995 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $232.45 to $232.91. The price reported above reflects the weighted average sale price. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 11,189 | $232.51 | $2,601,583.48 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · nonDerivative · entry 3 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,408 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $232.45 to $232.91. The price reported above reflects the weighted average sale price. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 16,888 | $58.24 | $983,557.12 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 23:18 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 1,145 | $58.24 | $66,684.80 |
DisclosureSEC source: 0001127602-22-022565 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 19:07 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 4,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-021422 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,564 F1 · kind: Represents performance-based restricted stock units granted on November 18, 2021. The shares were earned on August 18, 2022, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. F2 · balance_after: Includes 61.1855 shares of ResMed stock purchased on April 29, 2022, through the ResMed Employee Stock Purchase Plan. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 18:09 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-012108 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 18:09 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $233.29 | $1,866,320.00 |
DisclosureSEC source: 0001127602-22-012108 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 18:09 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-22-012108 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 18:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-009455 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 18:51 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $238.07 | $1,904,560.00 |
DisclosureSEC source: 0001127602-22-009455 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 18:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-22-009455 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 21:08 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-005282 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 21:08 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,000 | $235.81 | $1,886,480.00 |
DisclosureSEC source: 0001127602-22-005282 · form4.xml · nonDerivative · entry 2 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,175 F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 21:08 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 8,000 | $58.24 | $465,920.00 |
DisclosureSEC source: 0001127602-22-005282 · form4.xml · nonDerivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. Read SEC document |
| January 27, 2022 Filed Jan 31, 2022 22:04 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 15,000 | $0.00 Strike: $63.68 | $0.00 |
DisclosureSEC source: 0001209191-22-005623 · doc4.xml · derivative · entry 1 Douglas Robert Andrew · CIK 0001352232 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2032-01-27 F1 · derivative.exercise_date: These options were granted on January 27, 2022, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2023, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:40 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 8,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-22-001741 · form4.xml · derivative · entry 4 Douglas Robert Andrew · CIK 0001352232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,098 Underlying: ResMed Common Stock · 8,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was conducted under a Rule 10b5-1 plan. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest 1/3 per year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.